Calendar of Events Mobile Version

Robert Abraham, Ph.D., senior vice president and group head, oncology research and development, Pfizer Worldwide Research and Development

John Hardy, Ph.D., head, department of molecular neuroscience, chair, molecular biology of neurological disease, Institute of Neurology, University College London

Anja Groth, Ph.D., professor, group leader, Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark

Kodi Ravichandran, Ph.D., professor and chair, department of microbiology, immunology, and cancer biology, University of Virginia School of Medicine

Hanna Engelberg-Kulka, Ph.D., professor, The Hebrew University of Jerusalem

Kyle Loh, Ph.D., assistant professor, department of developmental biology, Stanford University School of Medicine

Andy Minn, M.D., Ph.D., Associate Professor of Radiation Oncology, University of Pennsylvania, Opposing Roles on Interferon Signaling Coordinate Innate and Adaptive Responses to Cancer Immune Checkpoint Blockade

Elizabeth Campbell, Ph.D., senior research associate, Laboratory of Molecular Biophysics, The Rockefeller University

Steven Reiner, M.D., Charles H. Revson Professor of Microbiology, Immunology, and Pediatrics, Columbia University

Christina Kurzthaler, Ph.D., postdoc, University of Innsbruck, Austria

John Rubinstein, Ph.D., Canada Research Chair, senior scientist, The Hospital for Sick Children, professor, departments of biochemistry and medical biophysics, University of Toronto

Elsa Flores, Ph.D., chair and senior member, department of molecular oncology, leader, cancer biology and evolution program, senior member, department of cutaneous oncology, Moffitt Cancer Center

Scott M. Sternson, Ph.D., group leader, Janelia Research Campus, Howard Hughes Medical Institute

Liisa Kauppi, Ph.D., assistant professor, genome-scale biology program, University of Helsinki

Anthony Hyman, Ph.D., director and group leader, Max Planck Institute of Molecular Cell Biology and Genetics

Marisol Soengas, Ph.D., head, melanoma group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Kai Wucherpfennig, M.D., Ph.D., professor and chair, department of cancer immunology and virology, Dana-Farber Cancer Institute; professor of microbiology and immunobiology, Harvard Medical School; professor of neurology, Brigham and Women’s Hospital and Harvard Medical School

Nicola Allen, Ph.D., assistant professor, molecular neurobiology laboratory, Hearst Foundation Development Chair, Salk Institute

Samantha Butler, Ph.D., associate professor, Brain Research Institute Neurobiology, University of California, Los Angeles

Frederic Charron, Ph.D., associate professor, department of medicine, Montreal Clinical Research Institute (IRCM), McGill University

Claude Desplan, Ph.D., professor, department of biology, director, Center for Developmental Genetics, New York University

Cagla Eroglu, Ph.D., associate professor of cell biology, Duke University

Marc Freeman, Ph.D., director and senior scientist, Vollum Institute

Mary Beth Hatten, Ph.D., Frederick P. Rose Professor, Laboratory of Developmental Neurobiology, The Rockefeller University

Arnold Kriegstein, M.D., Ph.D., professor, University of California, San Francisco

Ophir Shalem, Ph.D., assistant professor, University of Pennsylvania

David Fruman, Ph.D., professor, department of molecular biology and biochemistry, associate director, Cancer Research Institute, University of California, Irvine

Victor Borrell Franco, Ph.D., professor, developmental neurobiology, Institute of Neurosciences, Alicante, Spain

Peter Reddien, Ph.D., professor of biology, associate department head, member and associate director, Whitehead Institute, Massachusetts Institute of Technology; investigator, Howard Hughes Medical Institute

Charles Serhan, Ph.D., professor and director, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital; The Simon Gelman Professor of Anaesthesia (biochemistry and molecular pharmacology), Harvard Medical School

Lera Boroditsky, Ph.D., associate professor, University of California, San Diego

Kathleen Collins, Ph.D., professor, department of molecular and cell biology, University of California, Berkeley